These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34819070)

  • 61. Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis.
    Bartholomew TS; Tookes HE; Bullock C; Onugha J; Forrest DW; Feaster DJ
    Int J Drug Policy; 2020 Apr; 78():102716. PubMed ID: 32146348
    [TBL] [Abstract][Full Text] [Related]  

  • 62. "I held on to the police's leg for mercy": Experiences of adversity, risk and harm among people who inject drugs during an anti-drug drive in Dhaka, Bangladesh.
    Khan SI; Irfan SD; Khan MNM
    Int J Drug Policy; 2021 Jun; 92():103299. PubMed ID: 34030931
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Young and invisible: a qualitative study of service engagement by people who inject drugs in India.
    Ganapathi L; Srikrishnan AK; Martinez C; Lucas GM; Mehta SH; Verma V; McFall AM; Mayer KH; Hassan A; Rajan S; O'Cleirigh C; Harris SK; Solomon SS
    BMJ Open; 2021 Sep; 11(9):e047350. PubMed ID: 34548348
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 2018.
    Ohringer AR; Serota DP; McLean RL; Stockman LJ; Watt JP
    BMC Public Health; 2021 Jul; 21(1):1435. PubMed ID: 34289822
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs.
    Trayner KMA; Palmateer NE; Hutchinson SJ; Goldberg DJ; Shepherd SJ; Gunson RN; Tweed EJ; Priyadarshi S; Sumnall H; Atkinson A; McAuley A
    Int J Drug Policy; 2021 Apr; 90():102731. PubMed ID: 32331859
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.
    Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST
    Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Syringe sharing among people who inject drugs in London, Canada.
    Scheim AI; Bardwell G; Rachlis B; Mitra S; Kerr T
    Can J Public Health; 2018 Apr; 109(2):174-182. PubMed ID: 29981046
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique.
    Semá Baltazar C; Kellogg TA; Boothe M; Loarec A; de Abreu E; Condula M; Fazito E; Raymond HF; Temmerman M; Luchters S
    Int J Drug Policy; 2021 Apr; 90():103095. PubMed ID: 33429163
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs.
    Childs E; Assoumou SA; Biello KB; Biancarelli DL; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Bazzi AR
    Harm Reduct J; 2019 Feb; 16(1):14. PubMed ID: 30744628
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China.
    Yang Y; Latkin CA; Luan R; Yang C
    BMC Public Health; 2015 Sep; 15():885. PubMed ID: 26370245
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.
    Noroozi M; Noroozi A; Sharifi H; Harouni GG; Marshall BDL; Ghisvand H; Qorbani M; Armoon B
    Int J Behav Med; 2019 Feb; 26(1):50-58. PubMed ID: 30460445
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.
    Yang Y; Latkin C; Luan R; Yang C
    Int J Drug Policy; 2016 Jan; 27():113-20. PubMed ID: 26123897
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Psychosocial Barriers to Viral Suppression in a Community-based Sample of Human Immunodeficiency Virus-infected Men Who Have Sex With Men and People Who Inject Drugs in India.
    Prabhu S; McFall AM; Mehta SH; Srikrishnan AK; Kumar MS; Anand S; Shanmugam S; Celentano DD; Lucas GM; Solomon SS
    Clin Infect Dis; 2020 Jan; 70(2):304-313. PubMed ID: 30840989
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design, implementation, and monitoring of HIV service packages for people who inject drugs: An assessment of programs supported by the Global Fund in 46 countries.
    Burrows D; Falkenberry H; McCallum L; Parsons D; Ngoksin E; Zhao J; Kunii O
    Int J Drug Policy; 2021 Feb; 88():103036. PubMed ID: 33212370
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of COVID-19 on substance use disorder treatment services in Kenya: Qualitative findings from healthcare providers.
    Muller A; Akiyama MJ; Riback L; Nyakowa M; Musyoki H; Cherutich P; Kurth A
    Int J Drug Policy; 2022 Jul; 105():103710. PubMed ID: 35580533
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of the COVID-19 Pandemic on HIV Test Uptake Among People Who Inject Drugs in the Context of an HIV Outbreak.
    Trayner KMA; Yeung A; Palmateer NE; McAuley A; Wilkinson M; Craik J; Metcalfe R; Peters E; Shepherd SJ; Gunson RN; Carter D; Sills L; Hutchinson SJ
    AIDS Behav; 2024 Jun; 28(6):2131-2147. PubMed ID: 38649554
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City.
    Fong C; Mateu-Gelabert P; Ciervo C; Eckhardt B; Aponte-Melendez Y; Kapadia S; Marks K
    Drug Alcohol Depend; 2021 Apr; 221():108589. PubMed ID: 33621804
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors.
    Jarlais DD; Weng CA; Feelemyer J; McKnight C
    Drug Alcohol Depend Rep; 2023 Sep; 8():100171. PubMed ID: 37323939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.